• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动免疫和被动免疫在可传播性海绵状脑病预防和治疗中的潜力。

Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.

作者信息

Bade Steffen, Frey Andreas

机构信息

Research Center Borstel, Division of Mucosal Immunology, Borstel, Germany.

出版信息

Expert Rev Vaccines. 2007 Apr;6(2):153-68. doi: 10.1586/14760584.6.2.153.

DOI:10.1586/14760584.6.2.153
PMID:17408366
Abstract

Transmissible spongiform encephalopathies are fatal neurodegenerative disorders that affect humans and certain animals and are caused by prions. In most cases, infection occurs by ingestion of prions. Their long-time persistence in the environment creates a reservoir of potentially infectious matter that renders the eradication of the disease problematic. Unfortunately, no cure is available to date. Yet, for both the treatment of infected and the protection of uninfected individuals, active and passive immunizations have been shown to have a beneficial effect on the course of the disease. The current review provides an overview of such antibody-based approaches and assesses their feasibility and potential in prophylaxis and therapy of transmissible spongiform encephalopathies.

摘要

传染性海绵状脑病是一种致命的神经退行性疾病,会影响人类和某些动物,由朊病毒引起。在大多数情况下,感染是通过摄入朊病毒发生的。它们在环境中的长期存在形成了一个潜在传染源库,使得根除该疾病成为难题。不幸的是,迄今为止尚无治愈方法。然而,对于感染个体的治疗和未感染个体的保护而言,主动免疫和被动免疫已被证明对疾病进程有有益影响。本综述概述了此类基于抗体的方法,并评估了它们在传染性海绵状脑病预防和治疗中的可行性及潜力。

相似文献

1
Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.主动免疫和被动免疫在可传播性海绵状脑病预防和治疗中的潜力。
Expert Rev Vaccines. 2007 Apr;6(2):153-68. doi: 10.1586/14760584.6.2.153.
2
Cell culture models of transmissible spongiform encephalopathies.传染性海绵状脑病的细胞培养模型
Biochem Biophys Res Commun. 2001 Nov 30;289(2):311-6. doi: 10.1006/bbrc.2001.5941.
3
Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.用于可传播性海绵状脑病治疗干预的朊病毒蛋白特异性抗体。
Expert Opin Biol Ther. 2006 Mar;6(3):293-300. doi: 10.1517/14712598.6.3.293.
4
Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.抗朊病毒单克隆抗体在传染性海绵状脑病小鼠模型中的免疫治疗效果:药代动力学和药效学分析。
J Gen Virol. 2010 Jun;91(Pt 6):1635-45. doi: 10.1099/vir.0.018077-0. Epub 2010 Jan 27.
5
Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.抗朊病毒蛋白抗体的治疗特性:单价片段与二价抗体的体外比较研究
J Neuroimmunol. 2009 Apr 30;209(1-2):50-6. doi: 10.1016/j.jneuroim.2009.01.025. Epub 2009 Feb 20.
6
Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.用展示朊病毒肽的乳头瘤病毒样颗粒进行疫苗接种可诱导产生针对正常朊病毒蛋白的自身抗体,这些抗体可干扰感染细胞中病理性朊病毒蛋白的产生。
FEBS J. 2007 Apr;274(7):1747-58. doi: 10.1111/j.1742-4658.2007.05721.x. Epub 2007 Feb 20.
7
Human and animal spongiform encephalopathies are autoimmune diseases: a novel theory and its supporting evidence.人类和动物海绵状脑病是自身免疫性疾病:一种新理论及其支持证据。
Int Rev Neurobiol. 2005;63:155-90. doi: 10.1016/S0074-7742(05)63006-1.
8
Is vaccination against transmissible spongiform encephalopathy feasible?针对传染性海绵状脑病进行疫苗接种可行吗?
Rev Sci Tech. 2007 Apr;26(1):243-51.
9
Recent developments in prion immunotherapy.朊病毒免疫疗法的最新进展。
Curr Opin Immunol. 2004 Oct;16(5):594-8. doi: 10.1016/j.coi.2004.07.008.
10
Anti-prion antibodies for prophylaxis following prion exposure in mice.用于小鼠朊病毒暴露后预防的抗朊病毒抗体。
Neurosci Lett. 2003 Jan 23;336(3):185-7. doi: 10.1016/s0304-3940(02)01192-8.

引用本文的文献

1
Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti-prion compounds.蛋白质错误折叠循环扩增(PMCA)技术的适应性改造及其在抗朊病毒化合物筛选中的应用。
FASEB J. 2024 Jul 31;38(14):e23843. doi: 10.1096/fj.202400614R.
2
Prion protein-specific antibodies-development, modes of action and therapeutics application.朊病毒蛋白特异性抗体——研发、作用方式及治疗应用
Viruses. 2014 Oct 1;6(10):3719-37. doi: 10.3390/v6103719.
3
Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.神经退行性疾病的免疫疗法:聚焦于α-突触核蛋白病。
Pharmacol Ther. 2013 Jun;138(3):311-22. doi: 10.1016/j.pharmthera.2013.01.013. Epub 2013 Feb 4.
4
[Innovative treatment approaches for Alzheimer's disease. Immunotherapy].[阿尔茨海默病的创新治疗方法。免疫疗法]
Nervenarzt. 2008 Nov;79 Suppl 3:149-57; quiz 158. doi: 10.1007/s00115-008-2499-x.
5
Active and passive immunotherapy for neurodegenerative disorders.神经退行性疾病的主动和被动免疫疗法。
Annu Rev Neurosci. 2008;31:175-93. doi: 10.1146/annurev.neuro.31.060407.125529.
6
Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells.识别在人淋巴母细胞表面表达的朊病毒蛋白表位的人单链抗体片段(scFvs)抗体的产生。
BMC Biotechnol. 2007 Jul 2;7:38. doi: 10.1186/1472-6750-7-38.